InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,478.08
(
0.00%
)
US TECH 100
19,239.20
(
0.13%
)
Dow Jones
39,171.28
(
0.11%
)
Brent Oil
85.31
(
0.99%
)
Bitcoin
61,703.33
(
1.46%
)
Post# of 252399
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: AlpineBV_Miller post# 55266

Monday, 11/26/2007 1:28:58 PM

Monday, November 26, 2007 1:28:58 PM

Post# of 252399
>I think I am too nearsighted for the Kera product.<

Intacs are approved only for <=3 diopters and they do not correct for astigmatism. This is one of the reasons the demand for the product has been de minimus.

The two approved ICL’s are reversible — i.e. they can be removed in almost all cases without any lasting effect. This is probably their main advantage vs LASIK.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up